Sipactimet

Sipactimet combines metformin hydrochloride and sitagliptin for type 2 diabetes management. This oral medication helps control blood sugar levels when diet and exercise alone are insufficient. Suitable for adults with type 2 diabetes, it supports overall glycemic control. A widely prescribed combination therapy in the EU.

Sipactimet is used to improve blood sugar control in adults with type 2 diabetes. It combines two active ingredients: metformin hydrochloride, which reduces glucose production in the liver, and sitagliptin, which enhances insulin release after meals. This combination therapy is typically prescribed when diet, exercise, and metformin alone are not enough to manage blood sugar levels effectively. It is not used to treat type 1 diabetes.

Sipactimet helps maintain steady blood sugar levels throughout the day. Users may notice improved energy levels and reduced symptoms of high blood sugar, such as excessive thirst or frequent urination. Some individuals report better overall well-being when blood sugar is well-controlled. Effects vary by person and may take time to become noticeable.

Store Sipactimet at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Always check the expiration date before taking a dose. If you experience persistent nausea, stomach upset, or other unusual symptoms, consult a healthcare professional promptly.

Sipactimet may interact with alcohol, increasing the risk of lactic acidosis. Certain medications, such as diuretics or corticosteroids, can affect blood sugar levels and may require dose adjustments. Inform your doctor about all prescription, over-the-counter, and herbal products you are using to avoid potential interactions.